From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

SERMAS-Consejería de Sanidad

Public Authority/Government

www.comunidad.madrid/servicios/salud/innovacion-sanitariaMadrid, Spain
6 profile visits

About

The Servicio Madrileño de Salud is one of the largest public healthcare systems in Europe, comprising 37 hospitals, 424 primary care centers, public health services, and emergency medical services. It is also a Core Partner of EIT Health, Europe’s leading health innovation network supported by the European Institute of Innovation and Technology (EIT).

Areas of Activity

IHI Topic 1: IHI European healthcare incubator networkIHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studiesIHI Topic 3: Decode the immuno-science of age-related mediated diseasesHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancersHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes researchHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicinesHORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Representatives

Policymaker

SERMAS-Consejería de Sanidad

Biomedical/AI Engineer

SERMAS-Consejería de Sanidad